Suppr超能文献

眼睑鳞样汗管型导管癌:1 例临床病理相关性研究。

Squamoid Eccrine Ductal Carcinoma of the Eyelid: Clinicopathologic Correlation of a Case.

机构信息

Henry Ford Health System, Detroit, Michigan.

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.

出版信息

Ophthalmic Plast Reconstr Surg. 2022;38(3):e80-e82. doi: 10.1097/IOP.0000000000002116. Epub 2022 Apr 4.

Abstract

Squamoid eccrine ductal carcinoma (SEDC) is a rare cutaneous neoplasm that often manifests as a plaque or nodule in sun-exposed areas of older patients. Herein, the authors report the first case of SEDC in the eyelid. A 76-year-old man presented with a 2.5 × 1.5 mm area of left upper eyelid erythema, thickening, ulceration, and scaling with madarosis superotemporally just above the lash line. Full-thickness wedge biopsy demonstrated irregular epithelial tubules with nuclear atypia and focal squamous differentiation, consistent with SEDC. The patient underwent Mohs resection and has had no recurrence approximately 27 months after surgical removal. The authors present this case to raise awareness of SEDC to ophthalmologists as all previous cases have been described in the nonophthalmic literature. A full-thickness biopsy is recommended to avoid misdiagnosing SEDC as squamous cell carcinoma (SCC), a less aggressive tumor. With greater awareness, there may be increased recognition of this likely underreported, more malignant entity.

摘要

鳞样汗腺导管癌(SEDC)是一种罕见的皮肤肿瘤,常表现为老年患者暴露于阳光的部位的斑块或结节。本文作者报告了首例眼睑 SEDC。一位 76 岁男性因左眼上眼睑红斑、增厚、溃疡和鳞屑,以及在睫毛线以上的上方出现睫毛稀疏,就诊。全层楔形活检显示不规则的上皮小管伴核异型性和局灶性鳞状分化,符合 SEDC。患者接受了 Mohs 切除术,在手术切除后约 27 个月未复发。作者提出这一病例是为了提高眼科医生对 SEDC 的认识,因为之前所有的病例都在非眼科文献中描述过。建议进行全层活检,以避免将 SEDC 误诊为鳞状细胞癌(SCC),后者是一种侵袭性较低的肿瘤。随着认识的提高,可能会更多地认识到这种可能被低估的、更恶性的实体。

相似文献

1
Squamoid Eccrine Ductal Carcinoma of the Eyelid: Clinicopathologic Correlation of a Case.
Ophthalmic Plast Reconstr Surg. 2022;38(3):e80-e82. doi: 10.1097/IOP.0000000000002116. Epub 2022 Apr 4.
2
Squamoid Eccrine Ductal Carcinoma: An Aggressive Mimicker of Squamous Cell Carcinoma.
Am J Dermatopathol. 2019 Feb;41(2):140-143. doi: 10.1097/DAD.0000000000001214.
4
Squamoid Eccrine Ductal Carcinoma: Treatment and Outcomes.
Am J Dermatopathol. 2022 Apr 1;44(4):249-253. doi: 10.1097/DAD.0000000000002072.
5
Surgical management of recurrent squamoid eccrine ductal carcinoma of the scalp.
J Craniofac Surg. 2012 Jul;23(4):e276-8. doi: 10.1097/SCS.0b013e31824dfbd8.
6
Recurrent Squamoid Eccrine Ductal Carcinoma After Mohs Micrographic Surgery.
Dermatol Surg. 2021 Aug 1;47(8):1108-1110. doi: 10.1097/DSS.0000000000002953.
7
Squamoid eccrine ductal carcinoma: clinical, histological and immunohistochemical features.
Dermatol Online J. 2024 Apr 15;30(2). doi: 10.5070/D330263577.
8
Mohs micrographic surgery for squamoid eccrine ductal carcinoma.
Dermatol Surg. 2005 Nov;31(11 Pt 1):1462-4. doi: 10.2310/6350.2005.31219.
9
A case report of temple squamoid eccrine ductal carcinoma: A diagnostic challenge beneath the tip of the iceberg.
Dermatol Ther. 2020 Mar;33(2):e13213. doi: 10.1111/dth.13213. Epub 2020 Jan 12.
10
Eccrine Ductal Carcinoma of the Eyelid.
Ophthalmic Plast Reconstr Surg. 2023;39(6):e199-e202. doi: 10.1097/IOP.0000000000002465. Epub 2023 Jul 21.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验